Characterization of Myocardial Injury With High-Sensitivity Troponin

Area of Science:

• Cardiology
• Biomarkers
• Clinical Diagnostics

Background:

• High-sensitivity troponin I (hs-cTnI) aids acute coronary syndrome assessment.
• Limited data exists on hs-cTnI performance across myocardial injury types and its prognostic value.
• This study investigates hs-cTnI in various myocardial injury contexts and 30-day outcomes.

Purpose of the Study:

• To characterize myocardial injury types associated with elevated hs-cTnI.
• To analyze the impact of demographics and comorbidities on hs-cTnI levels.
• To evaluate hs-cTnI as a predictor of 30-day morbidity and mortality.

Main Methods:

• Retrospective analysis of 1,975 patients with hs-cTnI measurements.
• Defined elevated troponin using the 99th percentile cutoff.
• Reviewed charts for myocardial injury, comorbidities, and kidney dysfunction.
• Calculated 30-day mortality and readmission rates.

Main Results:

• 24% of patients had elevated hs-cTnI; 17% had myocardial injury, most commonly type 2 myocardial infarction.
• hs-cTnI sensitivity and specificity were 99% and 92%, respectively.
• Higher hs-cTnI levels correlated with type 1 myocardial infarction, male sex, Black race, non-Hispanic ethnicity, and inpatient status.
• Elevated hs-cTnI, age, heart disease, kidney dysfunction, and inpatient status predicted 30-day mortality.

Conclusions:

• Elevated hs-cTnI in ED/inpatient settings frequently results from type 2 myocardial infarction.
• Maximum hs-cTnI levels correlate with injury type, demographics, and comorbidities.
• hs-cTnI may serve as a predictor of short-term outcomes.